Browse
Submit Data
Databases
API
Help

Dataset Information

14 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Optimal allocations for two treatment comparisons within the proportional odds cumulative logits model.

ABSTRACT: This paper studies optimal treatment allocations for two treatment comparisons when the outcome is ordinal and analyzed by a proportional odds cumulative logits model. The variance of the treatment effect estimator is used as optimality criterion. The optimal design is sought so that this variance is minimal for a given total sample size or a given budget, meaning that the power for the test on treatment effect is maximal, or it is sought so that a required power level is achieved at a minimal total sample size or budget. Results are presented for three, five and seven ordered response categories, three treatment effect sizes and a skewed, bell-shaped or polarized distribution of the response probabilities. The optimal proportion subjects in the intervention condition decreases with the number of response categories and the costs for the intervention relative to those for the control. The relation between the optimal proportion and effect size depends on the distribution of the response probabilities. The widely used balanced design is not always the most efficient; its efficiency as compared to the optimal design decreases with increasing cost ratio. The optimal design is highly robust to misspecification of the response probabilities and treatment effect size. The optimal design methodology is illustrated using two pharmaceutical examples. A Shiny app is available to find the optimal treatment allocation, to evaluate the efficiency of the balanced design and to study the relation between budget or sample size and power.

SUBMITTER: Moerbeek M

PROVIDER: S-EPMC8059828 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

The proportional odds cumulative incidence model for competing risks.

Project description:We suggest an estimator for the proportional odds cumulative incidence model for competing risks data. The key advantage of this model is that the regression parameters have the simple and useful odds ratio interpretation. The model has been considered by many authors, but it is rarely used in practice due to the lack of reliable estimation procedures. We suggest such procedures and show that their performance improve considerably on existing methods. We also suggest a goodness-of-fit test for the proportional odds assumption. We derive the large sample properties and provide estimators of the asymptotic variance. The method is illustrated by an application in a bone marrow transplant study and the finite-sample properties are assessed by simulations.

| S-EPMC4608382 | biostudies-literature

Time-varying proportional odds model for mega-analysis of clustered event times.

Project description:Mega-analysis, or the meta-analysis of individual data, enables pooling and comparing multiple studies to enhance estimation and power. A challenge in mega-analysis is estimating the distribution for clustered, potentially censored event times where the dependency structure can introduce bias if ignored. We propose a new proportional odds model with unknown, time-varying coefficients, and random effects. The model directly captures event dependencies, handles censoring using pseudo-values, and permits a simple estimation by transforming the model into an easily estimable additive logistic mixed effect model. Our method consistently estimates the distribution for clustered event times even under covariate-dependent censoring. Applied to three observational studies of Huntington's disease, our method provides, for the first time in the literature, evidence of similar conclusions about motor and cognitive impairments in all studies despite different recruitment criteria.

| S-EPMC6402758 | biostudies-literature

Proportional odds ratio model for comparison of diagnostic tests in meta-analysis.

Project description:BackgroundConsider a meta-analysis where a 'head-to-head' comparison of diagnostic tests for a disease of interest is intended. Assume there are two or more tests available for the disease, where each test has been studied in one or more papers. Some of the papers may have studied more than one test, hence the results are not independent. Also the collection of tests studied may change from one paper to the other, hence incomplete matched groups.MethodsWe propose a model, the proportional odds ratio (POR) model, which makes no assumptions about the shape of ORp, a baseline function capturing the way OR changes across papers. The POR model does not assume homogeneity of ORs, but merely specifies a relationship between the ORs of the two tests. One may expand the domain of the POR model to cover dependent studies, multiple outcomes, multiple thresholds, multi-category or continuous tests, and individual-level data.ResultsIn the paper we demonstrate how to formulate the model for a few real examples, and how to use widely available or popular statistical software (like SAS, R or S-Plus, and Stata) to fit the models, and estimate the discrimination accuracy of tests. Furthermore, we provide code for converting ORs into other measures of test performance like predictive values, post-test probabilities, and likelihood ratios, under mild conditions. Also we provide code to convert numerical results into graphical ones, like forest plots, heterogeneous ROC curves, and post test probability difference graphs.ConclusionsThe flexibility of POR model, coupled with ease with which it can be estimated in familiar software, suits the daily practice of meta-analysis and improves clinical decision-making.

| S-EPMC539279 | biostudies-literature

Fitting Proportional Odds Model to Case-Control data with Incorporating Hardy-Weinberg Equilibrium.

Project description:Genetic association studies have been proved to be an efficient tool to reveal the aetiology of many human complex diseases and traits. When the phenotype is binary, the logistic regression model is commonly employed to evaluate the association strength of the genetic variants predispose to human diseases because the maximum likelihood estimator of the odds ratio based on case-control data is equivalent to that from the same model by taking the data as being arisen prospectively. This equivalence does not hold for the proportional odds model and using it to analyze the case-control data directly often results in a substantial bias. Through putting a parameter of the minor allele frequency in the modified likelihood function under the condition that the Hardy-Weinberg equilibrium law holds within controls, a consistent estimator is obtained. On the basis of it, we construct a score test statistic to test whether the genetic variant is associated with the diseases. Simulation studies show that the proposed estimator has smaller mean squared error than the existing methods when the genetic effect size is away from zero and the proposed test statistic has a good control of type I error rate and is more powerful than the existing procedures. Application to 45 single nucleotide polymorphisms located in the region of TRAF1-C5 genes for the association with four-level anticyclic citrullinated protein antibody from Genetic Analysis Workshop 16 further demonstrates its performance.

| S-EPMC4660314 | biostudies-literature

Predicting preference-based utility values using partial proportional odds models.

Project description:BACKGROUND: The majority of analyses on utility data have used ordinary least square (OLS) regressions to explore potential relationships. The aim of this paper is to explore the benefits of response mapping onto health dimension profiles to generate preference-based utility scores using partial proportional odds models (PPOM). METHODS: Models are estimated using EQ-5D data collected in the Health Survey for England and the predicted utility scores are compared with those obtained using OLS regressions. Explanatory variables include age, acute illness, educational level, general health, deprivation and survey year. The expected EQ-5D scores for the PPOMs are obtained by weighting the predicted probabilities of scoring one, two or three for the five health dimensions by the corresponding preference-weights. RESULTS: The EQ-5D scores obtained using the probabilities from the PPOMs characterise the actual distribution of EQ-5D preference-based utility scores more accurately than those obtained from the linear model. The mean absolute and mean squared errors in the individual predicted values are also reduced for the PPOM models. CONCLUSIONS: The PPOM models characterise the underlying distributions of the EQ-5D data better than models obtained using OLS regressions. Additional research exploring the effect of modelling conditional responses and two part models could potentially improve the results further.

| S-EPMC4118278 | biostudies-literature

Understanding Recession and Self-Rated Health with the Partial Proportional Odds Model: An Analysis of 26 Countries.

Project description:IntroductionSelf-rated health is demonstrated to vary substantially by both personal socio-economic status and national economic conditions. However, studies investigating the combined influence of individual and country level economic indicators across several countries in the context of recent global recession are limited. This paper furthers our knowledge of the effect of recession on health at both the individual and national level.MethodsUsing the Life in Transition II study, which provides data from 19,759 individuals across 26 European nations, we examine the relationship between self-rated health, personal economic experiences, and macro-economic change. Data analyses include, but are not limited to, the partial proportional odds model which permits the effect of predictors to vary across different levels of our dependent variable.ResultsHousehold experiences with recession, especially a loss of staple good consumption, are associated with lower self-rated health. Most individual-level experiences with recession, such as a job loss, have relatively small negative effects on perceived health; the effect of individual or household economic hardship is strongest in high income nations. Our findings also suggest that macroeconomic growth improves self-rated health in low-income nations but has no effect in high-income nations. Individuals with the greatest probability of "good" self-rated health reside in wealthy countries ($23,910 to $50, 870 GNI per capita).ConclusionBoth individual and national economic variables are predictive of self-rated health. Personal and household experiences are most consequential for self-rated health in high income nations, while macroeconomic growth is most consequential in low-income nations.

| S-EPMC4626113 | biostudies-literature

Optimal treatment allocations in space and time for on-line control of an emerging infectious disease.

Project description:A key component in controlling the spread of an epidemic is deciding where, when and to whom to apply an intervention. We develop a framework for using data to inform these decisions in realtime. We formalize a treatment allocation strategy as a sequence of functions, one per treatment period, that map up-to-date information on the spread of an infectious disease to a subset of locations where treatment should be allocated. An optimal allocation strategy optimizes some cumulative outcome, e.g. the number of uninfected locations, the geographic footprint of the disease or the cost of the epidemic. Estimation of an optimal allocation strategy for an emerging infectious disease is challenging because spatial proximity induces interference between locations, the number of possible allocations is exponential in the number of locations, and because disease dynamics and intervention effectiveness are unknown at out-break. We derive a Bayesian on-line estimator of the optimal allocation strategy that combines simulation-optimization with Thompson sampling. The estimator proposed performs favourably in simulation experiments. This work is motivated by and illustrated using data on the spread of white nose syndrome, which is a highly fatal infectious disease devastating bat populations in North America.

| S-EPMC6334759 | biostudies-literature

Semiparametric bayes' proportional odds models for current status data with underreporting.

Project description:Current status data are a type of interval-censored event time data in which all the individuals are either left or right censored. For example, our motivation is drawn from a cross-sectional study, which measured whether or not fibroid onset had occurred by the age of an ultrasound exam for each woman. We propose a semiparametric Bayesian proportional odds model in which the baseline event time distribution is estimated nonparametrically by using adaptive monotone splines in a logistic regression model and the potential risk factors are included in the parametric part of the mean structure. The proposed approach has the advantage of being straightforward to implement using a simple and efficient Gibbs sampler, whereas alternative semiparametric Bayes' event time models encounter problems for current status data. The model is generalized to allow systematic underreporting in a subset of the data, and the methods are applied to an epidemiologic study of uterine fibroids.

| S-EPMC3616323 | biostudies-literature

Adaptive testing for multiple traits in a proportional odds model with applications to detect SNP-brain network associations.

Project description:There has been increasing interest in developing more powerful and flexible statistical tests to detect genetic associations with multiple traits, as arising from neuroimaging genetic studies. Most of existing methods treat a single trait or multiple traits as response while treating an SNP as a predictor coded under an additive inheritance mode. In this paper, we follow an earlier approach in treating an SNP as an ordinal response while treating traits as predictors in a proportional odds model (POM). In this way, it is not only easier to handle mixed types of traits, e.g., some quantitative and some binary, but it is also potentially more robust to the commonly adopted additive inheritance mode. More importantly, we develop an adaptive test in a POM so that it can maintain high power across many possible situations. Compared to the existing methods treating multiple traits as responses, e.g., in a generalized estimating equation (GEE) approach, the proposed method can be applied to a high dimensional setting where the number of phenotypes (p) can be larger than the sample size (n), in addition to a usual small P setting. The promising performance of the proposed method was demonstrated with applications to the Alzheimer's Disease Neuroimaging Initiative (ADNI) data, in which either structural MRI driven phenotypes or resting-state functional MRI (rs-fMRI) derived brain functional connectivity measures were used as phenotypes. The applications led to the identification of several top SNPs of biological interest. Furthermore, simulation studies showed competitive performance of the new method, especially for p>n.

| S-EPMC5340645 | biostudies-literature

Designing optimal allocations for cancer screening using queuing network models.

Project description:Cancer is one of the leading causes of death, but mortality can be reduced by detecting tumors earlier so that treatment is initiated at a less aggressive stage. The tradeoff between costs associated with screening and its benefit makes the decision of whom to screen and when a challenge. To enable comparisons across screening strategies for any cancer type, we demonstrate a mathematical modeling platform based on the theory of queuing networks designed for quantifying the benefits of screening strategies. Our methodology can be used to design optimal screening protocols and to estimate their benefits for specific patient populations. Our method is amenable to exact analysis, thus circumventing the need for simulations, and is capable of exactly quantifying outcomes given variability in the age of diagnosis, rate of progression, and screening sensitivity and intervention outcomes. We demonstrate the power of this methodology by applying it to data from the Surveillance, Epidemiology and End Results (SEER) program. Our approach estimates the benefits that various novel screening programs would confer to different patient populations, thus enabling us to formulate an optimal screening allocation and quantify its potential effects for any cancer type and intervention.

| S-EPMC9182689 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data